Membrane traffic must be tightly, yet flexibly, regulated to control the composition of cellular compartments under changing physiological and developmental conditions [1] [2] [3] [4] . In epithelial cells, the transcytosis of pIgA by the pIgR is used as a model to study such regulation. Transcytosis of the pIgA-pIgR complex from the basolateral plasma membrane to the apical plasma membrane occurs in mucosal epithelia during immune defence 5 . The pIgR is targeted from the trans Golgi network (TGN) to the basolateral plasma membrane where it can bind pIgA, is endocytosed into endosomes and then transcytosed to the apical plasma membrane. Although pIgR is transcytosed in the absence of pIgA, binding of pIgA increases the efficiency and rate of transcytosis 6, 7 through initiation of a signal-transduction pathway; this is a paradigm for how the binding of cargo to a receptor can autoregulate traffic 8 . The regulation of pIgA transcytosis is also central for the understanding of mucosal immunity 9 . IgA-secreting plasma cells can produce more pIgA in response to infection and the ability of this increased pIgA to stimulate its own transcytosis enables coordination of transcytosis with other aspects of mucosal immunity. Furthermore, transcytosis is a universal mechanism for delivery of proteins to the apical surface of polarized epithelial cells. Therefore, understanding the regulation of the best-understood transcytotic pathway is of general importance 10 .
The binding of pIgA primarily stimulates pIgA-pIgR movement from apical recycling endosomes (AREs) to the apical plasma membrane, the last step in transcytosis 11 . Several small GTPases, Rab3b, Rab25, and Rab11a with its effector Rab11-FIP5 (also known as Rip11/pp75; throughout this paper referred to as FIP5), are enriched in the ARE and are involved in polarized protein recycling, and pIgA transcytosis [12] [13] [14] . Injection of pIgA into rats activates the Src family tyrosine kinase Yes, and pIgA-stimulated transcytosis is defective in Yes-knockout mice 15 . Thus, pIgA binding triggers signalling that promotes apical delivery of pIgA-pIgR through Yes activation in vivo. Identification of Yes substrates is central to understanding the regulation of pIgA transcytosis. Here, we identify a Yes substrate that, when phosphorylated, leads to activation of a kinase cascade that controls pIgA transcytosis.
RESULTS

EGFR is a direct substrate of Yes in rat liver endosomes
To identify substrates of Yes involved in transcytosis, we used a Yes mutant (T346G) fused to a GST tag (denoted as Yes-GTM) in in vitro kinase assays. Yes-GTM is myristoylated for membrane targeting, and is engineered to uniquely use only specific ATP analogues, which allowed us to detect direct substrates of Yes-GTM RRC) 5, 18 . To label only Yes-GTM substrates, endosomes were incubated with Yes-GTM and radiolabelled ATP analogue [γ- -(benzyl) ATP. Proteins of 170, 46 and 44 K were phosphorylated, reaching maximum levels of phosphorylation at 4 min (Fig. 1a, b) . These proteins were absent in controls lacking Yes-GTM. The general (PP2) or Yes-GTM-specific (1-NM-PP1; ref. 19 ) SFK inhibitors abolished phosphorylation (170 K band shown; Fig. 1c,  d ). PP3, an inactive analogue of PP2, demonstrated inhibition only at high concentration (Fig. 1c) .
We isolated the 170 K protein using antibodies against phosphorylated tyrosine ( Supplementary Information, Fig. S1 ). By mass spectrometry, it was identified as rat EGFR; seventeen peptides covered approximately 12% of the EGFR. We could not identify the 44 and 46 K species (Fig. 1a) because of co-migrating antibody heavy chain ( Supplementary Information, Fig.  S1 ). Simultaneous dual-colour immunoblotting confirmed that the 170 K phosphorylated tyrosine band precisely co-migrates with EGFR (Fig. 1e) .
Phosphorylation of EGFR in response to pIgA requires Yes
We confirmed that EGFR is phosphorylated in vivo in response to pIgA by injecting rats with pIgA, which binds to pIgR on hepatocytes 20 . After 1 min, we isolated endosomes 15 and detected total and phosphorylated EGFR by immunoprecipitation, followed by immunoblotting with anti-phosphorylated-tyrosine antibody. A 126.4 ± 26.2% increase in the ratio of phosphorylated tyrosine to total EGFR was observed in the RRC of pIgA-injected rats, compared with controls ( Fig. 2a , n = 3, P < 0.03). Thus, pIgA induces stimulation of EGFR phosphorylation in vivo.
Next, we studied stimulation of pIgA in MDCK cells expressing rabbit pIgR, which have been used similarly in previous studies. Immunoblots of lysates from pIgR-expressing MDCK cells treated with pIgA had a 170 K phosphorylated tyrosine band, which peaked at 1-5 min after pIgA treatment (Fig. 2b, control) . This band precisely co-migrated with the higher-molecular-weight EGFR band (as determined by dual-colour immunoblotting), and therefore represents EGFR with a phosphorylated tyrosine. Quantification of band intensity indicated that the ratio of phosphorylated tyrosine to total EGFR increased to 85 ± 26% at 5 min after the pIgA treatment, compared with cells at 0 min after pIgA treatment (n = 4, P < 0.01). We expressed Yes shRNA in pIgR-expressing MDCK cells, achieving approximately 90% protein reduction. Immunoblotting indicated that the higher-molecular-weight phosphorylated-tyrosine EGFR band induced by pIgA binding was abolished by Yes knockdown (Fig. 2b ), or treatment with PP2 (Fig. 2c) . No increase in EGFR phosphorylation was detected when parental MDCK cells (no pIgR) were treated with pIgA (data not shown). Thus, pIgA induces Yes-dependent phosphorylation of EGFR in MDCK cells expressing pIgR.
Next, we examined which EGFR tyrosine residues become phosphorylated in response to pIgA treatment using pIgR-expressing MDCK cells that also express human EGFR (hEGFR). On 5 min treatment with pIgA, EGFR phosphorylation increased significantly on Tyr 992 (71 ± 31%), with moderate increases on Tyr 1173 (36 ± 19%) and Tyr 845 (34 ± 11%) (n = 4, P < 0.03; Fig. 2d ). No significant increase was detected at Tyr 1068, Tyr 1086 or Tyr 1045. Thus, EGFR is a substrate of Yes in vitro and in vivo in a pathway stimulated by pIgA. P-labelled proteins were detected by a phosphorimager. PP3 is an inactive analogue of PP2. (e) Protein from endosomes was resolved by SDS-PAGE. Total (green) and phosphorylated EGFR (red) were identified by dual-colour infrared immunoblotting using antibodies specific to EGFR and phosphorylated tyrosine (pTyr). The phosphorylated tyrosine band occurs only in the presence of Yes-GTM, precisely co-migrating with EGFR. Uncropped images of blots are shown in Supplementary Information, Fig. S7 .
Formation of a pIgR-Yes-EGFR complex at basal state in endosomes In a previous study, Yes and pIgR were shown to co-immunoprecipitate 15 , so we tested if EGFR also co-immunoprecipitates with these proteins. We detected specific co-immunoprecipitation of pIgR, Yes and EGFR from solubilized liver endosomes, compared with no co-immunoprecipitation from non-specific serum (NSS; Fig. 3a) . pIgR, Yes and EGFR could also be co-immunoprecipitated from the lysate of MDCK cells expressing hEGFR and pIgR (Fig. 3b) . Co-immunoprecipitation efficiencies were approximately 10% (7-13.9%) (Fig. 3a, b) . This indicates the existence of a complex, or complexes, between pIgR, Yes and EGFR in MDCK cells, and in endosomes in vivo. We examined the possible location of pIgR, EGFR and Yes interaction in MDCK cells (Fig. 3c) . Partial co-localization of EGFR, pIgR and Yes in vesicles was most apparent in the sub-apical region (Fig. 3c , control cells) 21 , although some partial co-localization was observed near cell-cell contacts (Fig. 3 , control cells; middle). On addition of pIgA, pIgR labelling dispersed from this sub-apical pool (Fig. 3c, bottom) , representing apical transcytosis of pIgR. Dispersed pIgR vesicles were also seen laterally (Fig. 3c, bottom) . Quantification revealed partial co-localization of pIgR, IP -E G F R IP -p Ig R C e ll ly s a t e N S S C e ll ly s a t e Figure 3 Interaction and co-localization of EGFR, pIgR and Yes. (a) Rat liver endosomes were solubilized and EGFR, pIgR or Yes were immunoprecipitated. The proteins were resolved by SDS-PAGE and co-immunoprecipitation was assessed by immunoblotting. Immunoprecipitations with nonspecific rabbit serum (NSS) were performed as a negative control. In the RRC lane, 5 μg of protein was loaded as the input. The intensity of the co-immunoprecipitated protein bands are indicated, compared with the intensity of the immunoprecipitated protein bands (data are means ± s.e.m., n = 4). Boxes represent spliced regions from same gels, to maintain sample order format under all conditions. (b) pIgR, Yes or EGFR were immunoprecipitated from the lysates of MDCK cells expressing hEGFR and pIgR, and co-immunoprecipitation was detected by immunoblotting, as indicated. Immunoblotting of total cell lysates and immunoprecipitation and immunoblotting of non-specific serum (NSS) and was also performed. The intensity of the co-immunoprecipitated protein bands are indicated as a percentage of the intensity of the protein bands in the input lysate (data are means ± s.e.m., n = 3). Yes and EGFR primarily in the sub-apical region of cells ( Supplementary  Information, Fig. S2a ). Co-immunoprecipitation of this complex was similarly reduced on pIgA treatment ( Supplementary Information, Fig.  S2b, c) . Co-staining for the ARE-marker Rab11a revealed overlap with a pool of pIgR, but not EGFR, either with or without pIgA stimulation ( Supplementary Information, Fig. S2d, e) . These data suggest that pIgR, Yes and EGFR form a complex in the sub-apical region before entry into the Rab11a-positive ARE, and that pIgA induces release of pIgR from the complex, probably to allow apical delivery. Next, transport of the pIgA ligand was directly measured. We added biotinylated pIgA to the basolateral surface of MDCK cells and measured its apical release and intracellular retention. Overexpression of hEGFR caused a 3-fold increase in apical release at 15 min (Fig. 4b ) that declined by 60 min, similarly to the effect of EGF stimulation on apical-secretorycomponent release (Fig. 4a) . In contrast, Yes knockdown decreased pIgA transcytosis significantly at all times, especially early after addition of biotinylated pIgA, in agreement with reduced pIgA transcytosis reported in Yes knockout mice 15 . Thus, activation of EGFR is necessary and sufficient for enhancing transcytosis of pIgR.
Transcytosis of pIgA requires EGFR
Next, we tested the effect of expressing constitutively active EGFR on pIgA-pIgR transcytosis. Cells overexpressing wild-type EGFR formed polarized monolayers with basolateral EGFR ( (mitogen-activated protein kinase) pathways, respectively 22, 23 . We previously reported a role for PLCγ1 in pIgR transcytosis 24 and therefore focused on MAPK. Immunoblotting of rat liver endosomes demonstrated that ERK1 and ERK2 were present ( Supplementary Information,  Fig. S5a ). When pIgR-expressing MDCK cells were treated with pIgA, ERK phosphorylation was modestly, but significantly, induced on p44 and p42 ERK (increase in the ratio of phosphorylated ERK:ERK at 5 min of 149 ± 46%, compared with cells at 0 min of treatment; n = 4, P < 0.03; Fig. 5a ). No increase in ERK phosphorylation occurred on pIgA stimulation in cells with Yes knockdown (Fig. 5b) , or cells treated with SFK inhibitor (PP2; Fig. 5c ), EGFR inhibitor (PD153035; Fig. 5d ) or MEK (mitogen-activated protein kinase kinase) inhibitor (U0126; Fig. 5e ). Levels of phophorylated ERK were further increased by pIgA stimulation in cells overexpressing hEGFR, compared with parental cells (compare Fig. 5a and Supplementary Information, Fig. S5b ), corresponding to the enhanced transcytosis under this condition (Fig. 4b) . Thus, pIgA induces ERK phosphorylation and this requires Yes, EGFR and MEK/ERK.
Inhibition of ERK activation by treatment with MEK inhibitors (U0126 or PD98059) significantly reduced pIgA transcytosis (2-4-fold at 30 min; 2-2.7-fold at 60 min; Fig. 5f ) to levels observed with inhibition of SFK (PP2) or EGFR (PD153035; Fig. 5f ). Notably, U0126, and to a lesser extent PD98059, partially inhibited transcytosis of pIgR even in the absence of pIgA ( Supplementary Information, Fig. S5c, d) , possibly owing to the involvement of MEK/ERK in constitutive pIgR transcytosis. These data suggest that the MEK/ERK pathway is involved in transcytosis of pIgA-pIgR.
Phosphorylation of FIP5 by ERK regulates pIgR transcytosis
Activation of EGFR and downstream ERK1 or ERK2 induced rapid pIgR transcytosis. We examined phosphoproteomic databases (www.phosida.com) for membrane trafficking proteins that are phosphorylated in response to EGF, and possess potential ERK phosphorylation sequences. We focused on FIP5, a Rab11-interacting protein 14 , which possesses a conserved, canonical ERK phosphorylation site sequence (P-X-S/T-P, where X is any residue), at Ser 188 (Fig. 6a) .
In MDCK cells, FIP5 is enriched in the ARE, where in conjunction with Rab11a, it regulates transcytosis of pIgA-pIgR to the apical plasma membrane 14 . Rab11a and FIP5 are on rat liver endosomes (Fig. 6b) . We tested if FIP5 was required for pIgA-pIgR transcytosis, by knockdown of FIP5 (Fig. 6c, d ). Indeed, pIgA transcytosis was significantly reduced by 56 ± 0.05% (30 min) on FIP5 knockdown, compared with control cells (n = 4, P < 0.001; Fig. 6d ).
To examine whether FIP5 Ser 188 is a target for ERK, we stably expressed wild-type FIP5 or an S188A mutant, both tagged with GFP, in MDCK cells expressing pIgR (Fig. 6e) . Densitometric analysis of the immunoblots revealed that GFP-FIP5 expression (wild type or the S188A mutant) was approximately 3.8-fold higher than endogenous FIP5. Stimulation of these cells with pIgA resulted in rapid phosphorylation of GFP-FIP5, as assessed by immunoprecipitation of GFP-FIP5 followed by immunoblotting with antibodies against phosphorylated serine (phosphorylated serine/GFP-FIP5 ratio, 87 ± 26% increase when compared with controls at 5 min; n = 4, P < 0.001, Fig. 6f ). This phosphorylation peaked at 5-30 min and declined by 60 min (Fig. 6f) . The phosphorylated serine-FIP5 band runs as a smear on an immunoblot, suggesting phosphorylation at multiple sites. In contrast, the phosphorylated serine signal was abolished in cells expressing GFP-FIP5 S188A (Fig. 6f) , suggesting that Ser 188 is a key FIP5 phosphorylation residue. To confirm that FIP5 phosphorylation lay downstream of the Yes-EGFR-MAPK module, we treated wild-type cells with Yes (PP2), EGFR (PD153035) or MEK (U0126) inhibitors, before and during pIgA treatment. pIgA-induced GFP-FIP5 phosphorylation was abolished by these inhibitors (Fig. 6g) . Rab11-FIP mutants in Drosophila melanogaster delocalize Rab11a and myosin Vb, both of which regulate pIgA-pIgR transcytosis 13, 25, 26 . We examined whether expression of GFP-FIP5 S188A affected Rab11a localization in polarized monolayers. Similarly to previous reports 13, 14 , Rab11a localized to vesicles clustered in the middle of the sub-apical region of cells, largely overlapping with GFP-FIP5 (Fig. 7a) . pIgA stimulation dispersed FIP5-Rab11a vesicles through the sub-apical region. In cells expressing GFP-FIP5 S188A , both Rab11a and the FIP5 mutant co-labelled vesicles in and GFP-FIP5 (wild type or the S188A mutant). Cells were treated with biotinylated pIgA, which was allowed to accumulate intracellularly, followed by incubation. Transcytosed pIgA was measured at the indicated times. Data are means ± s.e.m. Asterisks indicate P < 0.001, n = 4. (c) MDCK cells expressing pIgR and GFP-FIP5 (green; wild type; top, or the S188A mutant; bottom) were treated basolaterally with biotinylated pIgA, and immunostained for pIgA (red) and F-actin (blue) after 60 min of transcytosis. Yellow, arrowheads indicate overlap of pIgA and wild-type GFP-FIP5 in the centre of the sub-apical region of cells. Images on the right are higher-magnification images of boxed areas indicated in images on the left. Scale bars, 20 μm. the periphery of cells, with or without pIgA stimulation (Fig. 7a, arrows) . This suggests that ERK-regulated phosphorylation of FIP5 regulates the polarized distribution of Rab11a-FIP5-labelled vesicles.
To determine whether FIP5 Ser 188 phosphorylation is required for transcytosis, cells expressing GFP-FIP5 (wild type versus the S188A mutant) were treated with biotinylated pIgA at the basolateral surface, before incubation to allow pIgA to accumulate intracellularly 21 . pIgA transcytosis was increased in cells overexpressing wild-type GFP-FIP5 at 60 min. In contrast, pIgA transcytosis was strikingly reduced in cells expressing GFP-FIP5 S188A , compared with wild-type GFP-FIP5 or parental pIgR-expressing MDCK cells (Fig. 7b, wild-type FIP5-versus  FIP5 
S188A
-expressing cells at 30-60 min, n = 4, P < 0.001; wild-type FIP5-expressing cells versus control at 30-60 min, n = 4, 30 min, P > 0.5 and 60 min, P < 0.016). Accordingly, analysis of pIgA localization in cells expressing GFP-FIP5 S188A , through immunofluorescence microscopy or immunoblotting of cell lysates, indicated intracellular accumulation of pIgA, compared with cells expressing wild-type GFP-FIP5 at 60 min ( Fig. 7c and Supplementary Information, Fig. S6a, b) , at which time the majority of pIgA has normally transcytosed (Fig. 7b) . In contrast to cells expressing wild-type GFP-FIP5, which displayed strong overlap with pIgA in vesicles, GFP-FIP5 S188A -expressing cells possess pIgA in vesicles distributed throughout the sub-apical cytoplasm, much of which did not overlap with the FIP5 mutant. These data reveal that ERK-regulated phosphorylation of FIP5 is critical for pIgA transcytosis.
DISCUSSION
Our data suggest a pathway where pIgA binding to pIgR activates Yes, followed by activation of EGFR and then the MEK-ERK module (presumably through Ras and Raf), which culminates in phosphorylation of FIP5, control of Rab11a localization and stimulation of transcytosis (Fig. 8a) . Earlier work indicated that regulation of pIgA transcytosis also involves calcium, kinases (protein kinase C; PKC and phosphatidylinositol 3-kinase; PI3Kinase), numerous Rabs (Rab3b, Rab5, Rab11a, Rab17 and Rab25), retromer and signals in the pIgR cytoplasmic domain 4, 5, [27] [28] [29] [30] . Thus, this cascade is part of a complex network governing transcytosis.
pIgR, EGFR and Yes formed a complex in sub-apical endosomes, which were devoid of the ARE marker Rab11a, suggesting that the complex may occur in apically located common recycling endosomes (CREs), before ARE entry (Fig. 8b) . pIgA stimulated dispersal of the complex, concomitant with apical transcytosis of pIgA-pIgR, which occurs through the ARE under control of Rab11a 21, 31 . EGFR knockdown not only attenuated pIgA-induced pIgR transcytosis, but also increased transport of non-receptor-bound pIgR to both the apical and basolateral surfaces, suggesting a fundamental requirement for EGFR in regulating pIgR transport to the apical surface.
Rab11a and FIP5 regulate pIgA transcytosis 14, 31 . Here, we demonstrate that ERK phosphorylation on FIP5 Ser 188 is crucial for efficient pIgApIgR transcytosis. pIgA-induced FIP5 phosphorylation is blocked by inhibitors of SFK, EGFR or MEK. Expression of a FIP5 S188A mutant disrupted polarized distribution of pIgA and Rab11a and led to co-accumulation of Rab11a/FIP5-labelled vesicles in the periphery of the sub-apical region, suggesting that Ser 188 phosphorylation controls localization of FIP5 and Rab11a. FIP5 S188A also functioned as a dominant-negative inhibitor of pIgA-induced transcytosis, suggesting that this EGFR/MEK/ ERK target is a critical residue in the regulation of transcytosis.
EGFR activation by tyrosine phosphorylation may regulate this network by coupling EGFR to numerous effectors with SH2 domains [32] [33] [34] . For example, EGFR phosphorylated at Tyr 992 phosphorylates and activates PLCγ 35, 36 . Phosphorylation of PLCγ1 increases in MDCK cells on pIgA binding 24 . The resultant phospholipid hydrolysis leads to activation of PKC and elevation of intracellular free calcium; both promote pIgR transcytosis 37, 38 . We now show that pIgA binding leads to phosphorylation of EGFR mainly at Tyr 992, Tyr 1173 and Tyr 845. The role of ERKs in pIgA transcytosis was focused on because ERK can be activated by phosphorylation of EGFR Tyr 1173/Tyr 992 through the Ras-Raf-MEK pathway [39] [40] [41] . ERK is abundant in rat liver endosomes and we show that EGFR functions, at least partly, by coupling pIgR to ERK, which is activated rapidly after pIgA stimulation. pIgA-induced phosphorylation of ERK was blocked by depleting or inhibiting either Yes or EGFR, suggesting that EGFR activates the MEK/ERK pathway in pIgR-containing endosomes.
This pathway links kinases that are traditionally viewed as regulating development (EGFR-MAPK-ERK) 42 with regulators of membrane traffic (Rab11a and FIP5 ). An explanation for this unusual connection is that the levels of phosphorylation and activation of these signalling components by pIgA are lower than usually seen in regulation of development (though statistically significant and reproducible). Indeed, constitutive EGFR activation perturbed, rather than promoted, transcytosis. Notably, ERK has also been found to directly phosphorylate and control the function of protrudin, another Rab11-interacting protein that regulates polarized endocytic sorting 43 . Furthermore, inhibition of the MEK-ERK pathway perturbs endosome morphology and recycling of molecules in ARF6-positive recycling vesicles 40 . Thus, in addition to the bistable regulation of developmental processes often associated with EGFR and kinase cascades, our data support an emerging model that endocytic machinery may be a common, but unappreciated, target of ERKs regulating membrane traffic in diverse contexts. Regulation of pIgA transcytosis involves transmission of information across the cell; ERK signalling is suited for such long distance signal transmission 44 . Regulation of membrane traffic is a central issue in cell biology. Indeed, many types of physiological adaptation as well as most developmental events involve regulation of membrane traffic 45 . One general type of traffic regulation is that the level of cargo can regulate its own transport. For example, an increase in the amount of newly synthesized secretory protein in the endoplasmic reticulum can lead to an increase in the amount of chaperones needed to properly fold the cargo, as well as in the amount of vesicular traffic leaving the endoplasmic reticulum 46 . The ability of the pIgR to increase its transcytosis in response to an increase in the amount of pIgA is a good model of this type of autoregulation.
Autoregulation of pIgA transcytosis is probably medically important. In response to mucosal infection, pIgA production can rapidly increase and autoregulation provides for its efficient transport into secretions. pIgA often forms a complex with antigen 47 and failure to adequately transport such antigen-antibody complexes may lead to their pathological deposition, such as in IgA nephropathy, a major cause of kidney failure worldwide 48 . Moreover, in IgA nephropathy, IgA complexes are abnormally deposited in renal glomeruli. This might cause abnormal activation of signalling by EGFR (or members of the EGFR family) leading to pathological proliferation, a hallmark of IgA nephropathy. The regulation of transcytosis by EGFR provides a rapid, post-transcriptional mechanism for coordinating response to infection or injury with mucosal immunity. pIgR is also transcriptionally upregulated by several cytokines, providing a complementary mechanism to coordinate pIgA transcytosis with mucosal immunity 49 . -(benzyl) ATP, the tyrosine kinase substrate peptide IYGEFKKK, and the specific inhibitor of mutated Yes kinase, 1-NM-PP1, were synthesized as previously described 19, [50] [51] [52] . l-[ 35 S]cysteine was purchased from PerkinElmer (Boston, MA). The inhibitor PP2 (used at 10 μM, or indicated concentrations), its inactive analogue PP3 (used at indicated concentrations), PD153035 (used at 2 μM) and PD98059 (used at 50 μM) were purchased from Calbiochem, U0126 (used at 10 μM) was from Promega. pIgA was provided by J. -P. Vaerman (Catholic University of Louvain, Belgium) and biotinylated using sulfo-NHS-LC-biotin (Pierce). EGF (used at 100 ng ml -1 ) was from Invitrogen. Purified polymeric rat pIgA (91C) was provided by J. Peppard (Wayne State University, USA). Biotinylated HRP was from Zymed, and Streptavidin was purchased from Sigma.
METHODS
Methods
Primary antibodies: mouse anti-Yes, clones 2.7 and 1373.7, a gift from J. Brugge (Harvard Medical School, USA; immunoblotting, 1:1,000; immunofluorescence microscopy, 1:100; immunoprecipitation, 1 μg per sample); anti-phosphorμg per sample); anti-phosphorg per sample); anti-phosphorylated tyrosine (4G10), from Upstate (immunoblotting, 1:1,000); phosphorylated Tyr-100 antibody, from Cell Signalling (immunoblotting, 1:1,000); rabbit anti-Yes, from Upstate (immunoblotting, 1:1,000; immunoprecipitation, 1 μg); sheep anti-EGFR, from Abcam and Fitzgerald (both antibodies: immunoblotting, 1:1,000; immunofluorescence microscopy, 1:200; immunoprecipitation, 1μg); rabbit anti-EGFR, mouse anti-pERK, rabbit anti-ERK1/2 and rabbit antimyosin light chain (MLC), from Santa Cruz (immunoblotting for all antibodies, 1:1,000); rabbit anti-phospho-EGFR kit, from Cell Signalling (immunoblotting, 1:1,000); mouse anti-biotin, from Jackson ImmunoResearch (immunoblotting, 1:1,000); rabbit anti-Rab11-FIP5 (pp75), provided by E. Chan (University of Florida, USA, through J. Goldenring, Vanderbilt University, USA; immunoblotting, 1:1,000); rabbit anti-GFP, from Molecular Probes (immunoprecipitation, 1 μg per sample); mouse anti-GFP from Roche Diagnostics (immunoblotting, 1:1,000); mouse anti-phosphorylated serine antibodies, from Calbiochem (immunoblotting, 1:500); rabbit anti-ERK conjugated to Alexa Fluor 680 (1:10,000); guinea pig anti-pIgR secretory component and sheep anti-secretory component, isolated in our lab (immunoblotting, 1:1,000; immunofluorescence microscopy, 1:300; immunoprecipitation, 1μg per sample); rabbit anti-pIgR (antibody 816), from J. -P. Vaerman (immunoblotting, 1:1,000; immunoprecipitation, 1μg per sample); rabbit anti-Rab11, from Zymed Laboratories (immunoblotting, 1:1,000; immunofluorescence microscopy, 1:100); mouse anti-GAPDH from Chemicon (immunoblotting, 1:10,000). Secondary antibodies for immunoblotting: Alexa 680 conjugated antibodies, from Molecular Probes (1:4,000); IRDye800 conjugated antibodies, from Rockland (1:3,000); HRP conjugated antibodies, from Jackson ImmunoResearch (1:10,000). Secondary antibodies for immunofluorescence microscopy staining: all Alexa dye-conjugated secondary antibodies were from Molecular Probes (1:200).
Plasmid construction, site-directed mutagenesis, protein expression and protein purification. The murine Yes cDNA was transferred from the vector pMIKNeo (provided by M. Sudol, Mount Sinai School of Medicine, USA) to pGEX4T-2 (Amersham Pharmacia). For cloning of mutant Yes (T346G) GST fusion protein, the full-length Yes coding sequence was constructed using two-step PCR. The Saccharomyces cerevisiae N-myristoyltransferase expression vector (pBB131) was provided by J. I. Gordon (Washington University, USA) 53 . The myristoylated mutant Yes GST fusion protein (Yes-GTM) was made by co-transformation of pGEX-4T containing mutant Yes and pBB131 containing the yeast N-myristoyltransferase into BL21-CodonPlus-RIL strain (Stratagene) as previously described 54 . Yes-GTM was purified by glutathione-Sepharose beads, as described 55 . pEGFP-C1-Rab11-FIP5 plasmid 56 was provided by M.W. McCaffrey (University College Cork, Ireland) and mutagenesis was performed by standard methods.
Cell lines, transfection and RNA interference. MDCK cell lines expressing rabbit pIgR were developed in our laboratory 57 . pWZLhygro-hEGFR wild-type, (provided by D. James and Q. Fan, UCSF, USA) and pBabe-puro-EGFR (Δ3/750P and L858R variants 58 ) viral vectors were used for EGFR variant expression. Amphotropic Phoenix cells (ATCC) were transfected with the viral vectors for virus production and viral supernatant was used to infect pIgR-expressing MDCK cells. Lentiviral shRNA constructs were used to target canine Yes (pPRIME vector 59 ), FIP5 (pLKO.1-puro vector 60 ), or EGFR (pLKO.1-blasticidin; developed in our laboratory). The RNAi sequences were as follows: Yes 1, forward, 5ʹ-AGGGTGACAATGTGAAACACTA-3ʹ, reverse 3ʹ-TAGTGTTTCACATTGTCACCCC-5ʹ; Yes 2, forward, 5ʹ-AGGT-GACAATGTGAAACACTAC-3ʹ, reverse 3ʹ-GTAGTGTT TCACA TTGTC-ACCC-5ʹ; FIP5, 5ʹ-(AA)TGGGAGCCACATTTACAAT-3ʹ; EGFR, 5ʹ-(AA) TCCCG TCTAT CACAATCAG-3ʹ. 293FT cells (Invitrogen) were co-transfected with the viral vector, and ViraPower Packaging mix (Invitrogen) for lentivirus production. The viral supernatant was used to infect pIgR-expressing MDCK cells, and stable knockdown cells were selected with appropriate antibiotic. Wild type and S188A mutant hEGFR-Rab11-FIP5 plasmids were transfected into pIgRexpressing MDCK cells, selected by G418, then sorted by fluorescence-activated cell sorting (FACS) to make stable lines. Protein knockdown level was assessed by immunoblotting followed by densitometric analysis of the bands, and calculating as follows: (control -knockdown)/control × 100%.
For all transcytosis assays, cell monolayers were grown on polycarbonate Transwell filters (plated 5 × 10 5 cells per 12 mm filter) for 4 days. pIgA binding assays using 0.3 mg ml -1 human pIgA were performed on monolayers preincubated in serum-free medium for 6-16 h.
pIgA injection and isolation of a rat liver endosome fraction. Male SpragueDawley rats (200-250 g) were from Charles River Laboratories, USA. Animals were treated according to the protocols approved by the UCSF Laboratory Animal Resource Center. Rat pIgA (10 mg per rat) was injected through a femoral vein 1 min before endosome isolation 15 . Rat liver endosome fractionation was performed as previously described, but here rats were not pre-treated with oestrogen and low-density lipoprotein (LDL) 61 . All steps were performed at 4 °C. The endosome fraction previously termed receptor-recycling compartment (RRC) was used for this study 18 . Protein concentration of endosome fractions was determined by the BCA (bicinchoninic acid) method (Pierce).
Protein kinase assays.
For measuring Yes-GTM activity, phosphorylation of the peptide substrate IYGEFKKK was determined by in vitro kinase assay, as previously described 16, 62 .
To identify the tyrosine-phosphorylated Yes-GTM substrates, 25 μg RRC fracμg RRC fracg RRC fraction was incubated with 0.5 μg Yes-GTM in the presence or absence of ATP analogues. The kinase reaction mixture had a final volume of 30 μl and conμl and conl and contained 10 mM Hepes at pH 7.4, 50 mM NaCl, 10 mM MnC1 2 , 10 mM MgCl 2 , 0.2 mM sodium orthovanadate, 1 mM NaF, 0.5 μg Yes-GTM, and 2.5 μCi [γ- -(benzyl) ATP. After 4 min, or as indicated, the reaction was stopped by adding 15 μl of SDS (sodium dodecyl sulfate)-sample buffer containing DTT (dithiothreitol). The samples were then processed for SDS-PAGE . The gels were scanned in a phosphorimager for radioactively labelled ATP analogues. In experiments with unlabelled ATP analogues, the separated proteins were transferred onto PVDF (polyvinylidene fluoride) membranes for immunoblotting.
Affinity purification of phosphotyrosine proteins for mass spectrometry. The RRC endosome fraction (0.5-0.7 mg protein) was incubated with 5 μg Yes-GTM with or without 0.1 mM N 6 -(benzyl) ATP. Then, endosomes were precipitated by centrifugation and solubilized in a solution containing 0.5% NP40, 20 mM Hepes at pH 7.4, 125 mM NaCl, 1 mM NaF, 1 mM sodium orthovanadate and protease inhibitors. Tyrosine phosphorylated proteins were immunoprecipitated by antiphosphorylated tyrosine (4G10 antibody)-coupled protein A beads and separated in 7.5% (v/v) SDS-PAGE gels. Protein gels were silver stained and the bands of interest were sequenced by mass spectrometry as previously described 28 .
Immunoblotting and co-immunoprecipitation. For immunoblotting, equal amounts of protein from endosomes, or cell lysates (10-20 μg protein per lane), were processed for SDS-PAGE. PVDF membranes were blocked using LI-COR blocker buffer (LI-COR Biosciences). Protein bands were visualized by Odyssey NIR Imager scanner (LI-COR Biosciences) or enhanced chemiluminescence (ECL; Thermo Scientific). Co-immunoprecipitation was performed as described 28 . For immunoprecipitation, 30−50 μg of protein from endosomes, or 1−1.5 mg of protein from cell lysate, per sample, was used. Endosomes were solubilized with non-ionic detergent. Band intensities were quantified using the Odyssey NIR Imager analysis system as described 63 , or the Quantity One program (Bio-Rad), for ECL detection. Radioactively labelled proteins were scanned using a Storm840 scanner (Amersham Biosciences) and band intensities were quantified using the ImageQuant software (Molecular Dynamics, Amersham).
Immunofluorescence microscopy, confocal microscopy and image analysis. Cells were grown on Transwell filters for indicated times, then fixed in 4% (v/v) paraformaldehyde and processed for immunofluorescence microscopy staining as previously described 21 . pIgA treatment was for 15 min. Confocal microscopy images, including stacks, were acquired using a Zeiss LSM510 confocal microscope, and image analysis was performed using accompanying software or Adobe Photoshop and Illustrator for image contrast. For co-localization quantification, Zeiss LSM510 software was utilized to either calculate Pearson's correlation coefficient (R 2 ), from images containing ≥ 50 cells, or for x-z reconstructions from confocal microscopy stacks.
pIgR secretory component delivery and pIgA transcytosis assays. These assays are as previously described 6, 24 . Sheep anti-secretory-component antibodies crosslinked to protein G beads were used to immunoprecipitate 35 S-labelled pIgR and secretory components. Guinea pig anti-secretory component and mouse antibiotin antibodies were used for immunoprecipitation and immunoblotting of biotinylated secretory components.
For general pIgA transcytosis assays, cells were treated with 100 μg ml -1 biotinylated pIgA at the basolateral surface at 37 °C for 15−60 min as indicated in Figures 4b, 5f and 6d. For pIgA transcytosis and pIgA subapical accumulation at 17 °C (Fig. 7b ), cells were treated with biotinylated pIgA at the basolateral surface for 10 min at 37 °C, then washed at 17 °C for 30 min to accumulate pIgA intracellularly 21 . Apically released pIgA was measured after incubation at 37 °C for 30-60 min. The apical medium samples and the cell lysates were collected for ELISA analysis. Apically transcytosed pIgA was calculated as the percentage of total pIgA (apical pIgA plus intracellular pIgA).
ELISA (enzyme-linked immunosorbent assay) for pIgA transcytosis analysis.
The amount of biotinylated pIgA, collected from either the apical medium after transcytosis or remaining in cells, was measured by ELISA. Briefly, Streptavidincoated 96-well plates were blocked with 2% (w/v) BSA (bovine serum albumin) in PBS. Samples collected at different times, were diluted in 2% BSA in 0.5% (v/v) PBST (phosphate-buffered saline Tween 20) and pre-incubated at 37 °C for 1 h. Wells were first treated with mouse anti-biotin antibody (1:5000) for 2 h at 37 °C, and then with HRP-conjugated rabbit anti mouse IgG (1:10,000) for 1 h at 37 °C. TMB (3, 3´, 5, 5´-tetramentylbenzidine) substrate (kit from Pierce) was used for detection. Data was analysed by Softmax (Molecular Device). A similar ELISA was also performed to measure fluid-phase transcytosis of biotinylated HRP.
Statistics. Data are expressed as means ± s.e.m. Student's t test was used to compare differences between treated groups relative to their paired controls. P values are indicated in the text and figures above the two groups compared.
Transepithelial resistance (TER) measurements. TER was measured using an epithelial volt-ohm meter, Millicell-ERS (Millipore, Billerica, MA) for filter grown cells. The absolute TER values were determined according to manufacturer's instructions. s u p p l e m e n ta r y i n f o r m at i o n www.nature.com/naturecellbiology 1 DOI: 10.1038/ncb2118
Figure S1
Identification of EGFR as a Yes substrate on rat liver endosomes by affinity purification and mass spectrometry. Tyrosine-phosphorylated proteins from rat liver endosomes were affinity purified by antiphosphotyrosine (4G10, pY100) antibodies from a kinase reaction (t = 4 min; see methods). The 170 kD band (indicated with * ) was identified as rat EGFR by mass spectrometry. Presented is a representative silver stained gel used for mass spectrometric analysis. Note, the 170 kD band could only be isolated using 4G10. 
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